Search

everythinglearnresearchcommunity

for

Search:↓

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Wnt/beta-catenin signaling in the skin helps fat cell development during hair growth and repair.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

The research found that different types of fibroblasts are involved in wound healing and that some blood cells can turn into fat cells during this process.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Mutant mice help researchers understand hair growth and related genetic factors.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Targeting the skin's endocannabinoid system could help treat skin disorders.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Both mouse and rat models are effective for testing alopecia areata treatments.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Alefacept may effectively treat severe lichen planus, with patients showing significant improvement and no side effects.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.